Prof. Dr. Osman Hakan Leblebicioğlu

ანკარის უნივერსიტეტის მედიცინის ფაკულტეტი — სამედიცინო განათლება

ანკარის საავადმყოფო — ინფექციური დაავადებებისა და კლინიკური მიკრობიოლოგიის სპეციალიზაცია

ონდოქუზ მაისის უნივერსიტეტის მედიცინის ფაკულტეტი — ასისტენტ-პროფესორი, ასოცირებული პროფესორი და პროფესორი

ინფექციური დაავადებები და კლინიკური მიკრობიოლოგია, VM Medical Park Samsun

Samsun Liv Hospital

Ondokuz Mayıs University-ის მედიცინის ფაკულტეტი

Ankara Hospital

ცხელებით მიმდინარე დაავადებები

გამონაყარით მიმდინარე ინფექციები

ქრონიკული ვირუსული ჰეპატიტები

HIV/AIDS

დიაბეტური ტერფის ინფექციები

პარაზიტული დაავადებები

დიარეა

მოგზაურობასთან დაკავშირებული ინფექციები

World Association of Medical Editors (WAME)

Committee on Publication Ethics (COPE)

European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

თურქეთის ინფექციური დაავადებებისა და კლინიკური მიკრობიოლოგიის სპეციალისტთა ასოციაცია (EKMUD)

თურქეთის მიკრობიოლოგიის საზოგადოება (TMC)

ვირუსული ჰეპატიტის პრევენციის ასოციაცია (VHSD)

სამსუნის ექიმთა პალატა

ESCMID-ის მოგზაურთა ინფექციების შემსწავლელი ჯგუფის საპატიო თავმჯდომარე

International Nosocomial Infection Control Consortium (INICC), თურქეთის კოორდინატორი

Annals of Clinical Microbiology and Antimicrobials — დამფუძნებელი და მთავარი რედაქტორი

Travel Medicine and Infectious Disease — რედაქტორი

Rello J, Manuel O, Eggimann P, Richards G, Wejse C, Petersen JE, Zacharowski K, Leblebicioglu H; ESGCIP and ESGITM. Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients. Int J Infect Dis. 2016 Jul;48:104-12. doi: 10.1016/j.ijid.2016.04.020. Epub 2016 Apr 28.

Rodriguez-Morales AJ, Alhazmi AH, Katime A, Hameed AA, Morales A, Lepetic AC, Risquez A, Forero-Delgadillo AJ, Holguin A, Faccini-Martínez ÁA, Guerrero A, Ribeiro A, Al Balushi A, Taylan Ozkan A, Rathish B, Diaz B, Porras-Pedroza BE, Hunsajarupan B, Lakatos B, Álvarez-Moreno C, Torres-Martinez CN, Ronnberg C, Perret C, Wejse CM, Adhikari A, Popescu CP, Abbara A, Biscayart C, Bonilla-Aldana DK, Fasan D, Calderon D, de Luna D, Forero-Peña DA, Costescu-Strachinaru DI, Mendes Pedro D, Monk EJM, Iliaki E, Pontali E, Ngbede EO, Farkas FB, González-Sanz M, Escarrá F, Mariotti F, Norman FF, Di Gennaro F, Membrillo FJ, Arrieta G, Guido G, Fuster ÁV, Grandez-Castillo GA, Leblebicioglu H, de Jong HK, Vargas H, Kim JA, Cardona-Ospina JA, Torres JR, Llenas-García J, Wagenhäuser I, Oteo JA, Gallegos Braun JF, Sepulveda-Arias JC, Hernandez JP, Ruíz Sáenz J, Nwofe JO, Kowalska J, Jackson KE, Aykac K, Rezzonico LF, Reyes LF, Frallonardo L, Krone M, Malagón MF, Sempere-Alcocer MA, Luque MT, Carlos M, Del Mar Faraco Oñorbe M, Segura Moreno M, Lauriola M, Masana M, Fernandez M, Martinez-Gutierrez M, Diaz-Menendez M, Martinez MJ, Cabada MM, Morante-Ruiz M, Alvarez-Martinez MJ, Sandoval-Paiz N, … Yellow fever in South America - A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN. Travel Med Infect Dis. 2025 Sep-Oct;67:102871. doi: 10.1016/j.tmaid.2025.102871. Epub 2025 Jun 27.

Sunbul M, Cerik HO, Cerik B, Gulel O, Leblebicioglu H. Enterococcus durans Endocarditis. Am J Ther. 2018 Nov/Dec;25(6):e663-e665. doi: 10.1097/MJT.0000000000000519.

Rodriguez-Morales AJ, Lopez-Echeverri MC, Perez-Raga MF, Quintero-Romero V, Valencia-Gallego V, Galindo-Herrera N, López-Alzate S, Sánchez-Vinasco JD, Gutiérrez-Vargas JJ, Mayta-Tristan P, Husni R, Moghnieh R, Stephan J, Faour W, Tawil S, Barakat H, Chaaban T, Megarbane A, Rizk Y, Sakr R, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Millán-Oñate J, Lopardo G, Barbosa AN, Cimerman S, Chaves TDSS, Orduna T, Lloveras S, Rodriguez-Morales AG, Thormann M, Zambrano PG, Perez C, Sandoval N, Zambrano L, Alvarez-Moreno CA, Chacon-Cruz E, Villamil-Gomez WE, Benites-Zapata V, Savio-Larriera E, Cardona-Ospina JA, Risquez A, Forero-Peña DA, Henao-Martínez AF, Sah R, Barboza JJ, León-Figueroa DA, Acosta-España JD, Carrero-Gonzalez CM, Al-Tawfiq JA, Rabaan AA, Leblebicioglu H, Gonzales-Zamora JA, Ulloa-Gutiérrez R. The global challenges of the long COVID-19 in adults and children. Travel Med Infect Dis. 2023 Jul-Aug;54:102606. doi: 10.1016/j.tmaid.2023.102606. Epub 2023 Jun 8.

Rodriguez-Morales AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Camacho-Moreno G, Mendoza H, Rodriguez-Sabogal IA, Millán-Oñate J, Lopardo G, Arce OA, Cimerman S, Chaves TDSS, Orduna T, Lloveras S, Cabrera M, Thormann M, Özsürekçi Y, Pérez-Sánchez C, Sandoval N, Zambrano L, Alvarez-Moreno CA, Chacon-Cruz E, Villamil-Gomez WE, Arteaga-Livias K, Savio-Larriera E, Cardona-Ospina JA, Risquez A, Forero-Peña DA, Contreras K, Sah R, León-Figueroa DA, Acosta-España JD, Sierra L, López-Delgado DS, Solarte-Portilla MA, Escobedo AA, Haque S, Amer FA, Leblebicioglu H, Ulloa-Gutierrez R, Galan-Rodas E, Matsee W, Fernandez ML, Echazarreta S, Cabieses B, Espinal C, Brea J, Navarro JC, Lezcano VG, Otero-Maldonado M, Echevarría-Cofiño R, Diaz B, Quispe-Torrez PP, Angerami RN, Avila-Aguero ML, Debbag R, Guevara ME, Carrero Y, Torres-Martinez CN, Membrillo FJ, Suarez JA. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama. Travel Med Infect Dis. 2025 May-Jun;65:102839. doi: 10.1016/j.tmaid.2025.102839. Epub 2025 Mar 18.

Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, Leblebicioglu H. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23. doi: 10.1186/s12941-020-00368-w.

Rodriguez-Morales AJ, León-Figueroa DA, Romaní L, McHugh TD, Leblebicioglu H. Vaccination of children against COVID-19: the experience in Latin America. Ann Clin Microbiol Antimicrob. 2022 Mar 25;21(1):14. doi: 10.1186/s12941-022-00505-7.

Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013 Jul;13(7):429-37. doi: 10.1089/vbz.2012.1061. Epub 2013 May 10.

Leblebicioglu H, Ozaras R. Syrian refugees and infectious disease challenges. Travel Med Infect Dis. 2015 Nov-Dec;13(6):443-4. doi: 10.1016/j.tmaid.2015.11.007.

Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation. 2018 Feb;102(2S Suppl 2):S66-S71. doi: 10.1097/TP.0000000000002013.

Farahat RA, Abdelaal A, Shah J, Ghozy S, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, McHugh TD, Leblebicioglu H. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ann Clin Microbiol Antimicrob. 2022 Jun 15;21(1):26. doi: 10.1186/s12941-022-00518-2.

Tutal E, Ozaras R, Leblebicioglu H. Systematic review of COVID-19 and autoimmune thyroiditis. Travel Med Infect Dis. 2022 May-Jun;47:102314. doi: 10.1016/j.tmaid.2022.102314. Epub 2022 Mar 18.

Gumusova S, Sunbul M, Leblebicioglu H. Ebola virus disease and the veterinary perspective. Ann Clin Microbiol Antimicrob. 2015 May 28;14:30. doi: 10.1186/s12941-015-0089-x.

Ozaras R, Leblebicioglu H, Sunbul M, Tabak F, Balkan II, Yemisen M, Sencan I, Ozturk R. The Syrian conflict and infectious diseases. Expert Rev Anti Infect Ther. 2016 Jun;14(6):547-55. doi: 10.1080/14787210.2016.1177457. Epub 2016 Apr 27.

Leblebicioglu H, Ozaras R, Fletcher TE, Beeching NJ; ESCMID Study Group for Infections in Travellers and Migrants (ESGITM). Crimean-Congo haemorrhagic fever in travellers: A systematic review. Travel Med Infect Dis. 2016 Mar-Apr;14(2):73-80. doi: 10.1016/j.tmaid.2016.03.002. Epub 2016 Mar 10.

Abbara A, González-Sanz M, AlKharrat A, Khalife M, Elferruh Y, Almhawish N, Abbara S, Marroush S, Shortall C, Ahmed SH, Alhazmi A, Alvarez-Martinez MJ, Asaduzzaman M, Al Balushi A, Barboza AP, Brekke H, Di Carlo P, Cascio A, Chiodini P, Colpani A, Díaz-Menéndez M, Elkheir N, Farkas FB, Garg P, Grüner B, Guimarães AR, Holmberg V, Ioannou P, Jordão S, Kim JA, Lakatos B, Leblebicioglu H, Llenas-García J, Losada-Galván I, Martinez GE, Monk EJM, Nedu E, Nwofe JO, O'Regan R, Paggi R, Pinho JH, Pontali E, Priyadarshi M, Rath B, Rathish B, Rezzonico LF, Rizk N, Ronnberg C, Morante-Ruiz M, Salvati A, Scarso S, Sempere-Alcocer MA, Sepulcri C, Costescu Strachinaru DI, Tamarozzi F, Tavares R, Ursini T, Verweij JJ, Wejse CM, Rodriguez-Morales AJ; ESGITM and ESGCP. Leishmaniasis in Syria - A call for action of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Travellers and Migrants (ESGITM) and for Clinical Parasitology (ESGCP). Travel Med Infect Dis. 2025 Jul-Aug;66:102849. doi: 10.1016/j.tmaid.2025.102849. Epub 2025 Apr 2.

Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob. 2018 May 2;17(1):17. doi: 10.1186/s12941-018-0269-6.

Leblebicioglu H, Ozaras R, Irmak H, Sencan I. Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges. Antiviral Res. 2016 Feb;126:21-34. doi: 10.1016/j.antiviral.2015.12.003. Epub 2015 Dec 13.

Dilek A, Ozaras R, Ozkaya S, Sunbul M, Sen EI, Leblebicioglu H. COVID-19-associated mucormycosis: Case report and systematic review. Travel Med Infect Dis. 2021 Nov-Dec;44:102148. doi: 10.1016/j.tmaid.2021.102148. Epub 2021 Aug 26.

Akinci E, Bodur H, Sunbul M, Leblebicioglu H. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever. Antiviral Res. 2016 Aug;132:233-43. doi: 10.1016/j.antiviral.2016.06.011. Epub 2016 Jul 1.

Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S43-6. doi: 10.1016/j.ijantimicag.2010.06.020.

Rello J, Leblebicioglu H; members of ESGCIP. Sepsis and septic shock in low-income and middle-income countries: need for a different paradigm. Int J Infect Dis. 2016 Jul;48:120-2. doi: 10.1016/j.ijid.2016.04.017. Epub 2016 Apr 25.

Kaya T, Dilek A, Ozaras R, Balcik OS, Leblebicioglu H. COVID 19 and febrile neutropenia: Case report and systematic review. Travel Med Infect Dis. 2022 May-Jun;47:102305. doi: 10.1016/j.tmaid.2022.102305. Epub 2022 Mar 7.

Alp E, Leblebicioglu H, Doganay M, Voss A. Infection control practice in countries with limited resources. Ann Clin Microbiol Antimicrob. 2011 Oct 22;10:36. doi: 10.1186/1476-0711-10-36.

Yilmaz H, Yilmaz EM, Leblebicioglu H. Barriers to access to hepatitis C treatment. J Infect Dev Ctries. 2016 Apr 28;10(4):308-16. doi: 10.3855/jidc.7849.

Ulger F, Dilek A, Esen S, Sunbul M, Leblebicioglu H. Are healthcare workers' mobile phones a potential source of nosocomial infections? Review of the literature. J Infect Dev Ctries. 2015 Oct 29;9(10):1046-53. doi: 10.3855/jidc.6104.

Leblebicioglu H, Sunbul M, Memish ZA, Al-Tawfiq JA, Bodur H, Ozkul A, Gucukoglu A, Chinikar S, Hasan Z. Consensus report: Preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival. Int J Infect Dis. 2015 Sep;38:9-15. doi: 10.1016/j.ijid.2015.06.029. Epub 2015 Jul 14.

Ahmed N, Leblebicioglu H. India's 'gold mine' of ancestral bacilli and the looming TB-HIV pandemic. Ann Clin Microbiol Antimicrob. 2006 Dec 22;5:31. doi: 10.1186/1476-0711-5-31.

Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, López-Vélez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, Huprikar S, Molina I, Mourão PHO, Kotton CN, Aguado JM; working group on Endemic Disease and Travel Medicine in Solid-Organ Transplantation. Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. Transplantation. 2018 Feb;102(2):193-208. doi: 10.1097/TP.0000000000002027.

Leblebicioglu H, Rodriguez-Morales AJ, Rossolini GM, López-Vélez R, Zahar JR, Rello J; ESGCIP and ESGITM. Management of infections in critically ill returning travellers in the intensive care unit-I: considerations on infection control and transmission of resistance. Int J Infect Dis. 2016 Jul;48:113-7. doi: 10.1016/j.ijid.2016.04.019. Epub 2016 Apr 28.

Ozaras R, Leblebicioglu H. Medical Considerations before International Travel. N Engl J Med. 2016 Oct 13;375(15):e32. doi: 10.1056/NEJMc1610671.

Pshenichnaya NY, Leblebicioglu H, Bozkurt I, Sannikova IV, Abuova GN, Zhuravlev AS, Barut S, Shermetova MB, Fletcher TE. Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey. Int J Infect Dis. 2017 May;58:58-64. doi: 10.1016/j.ijid.2017.02.019. Epub 2017 Feb 27.

Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, Senturk GC. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2012 Sep;12(9):805-11. doi: 10.1089/vbz.2011.0896. Epub 2012 May 18.

Hullegie SJ, Arends JE, Rijnders BJ, Irving WL, Salmon D, Prins M, Wensing AM, Klenerman P, Leblebicioglu H, Boesecke C, Rockstroh JK, Hoepelman AI. Current knowledge and future perspectives on acute hepatitis C infection. Clin Microbiol Infect. 2015 Aug;21(8):797.e9-797.e17. doi: 10.1016/j.cmi.2015.03.026. Epub 2015 Apr 16.

Rabaan AA, Al-Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, Pathak M, Malik YS, Dhama K, Singh KP, Bonilla-Aldana DK, Haque S, Martinez-Pulgarin DF, Rodriguez-Morales AJ, Leblebicioglu H. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020 Sep 2;19(1):40. doi: 10.1186/s12941-020-00384-w.

Al-Abri SS, Abaidani IA, Fazlalipour M, Mostafavi E, Leblebicioglu H, Pshenichnaya N, Memish ZA, Hewson R, Petersen E, Mala P, Nhu Nguyen TM, Rahman Malik M, Formenty P, Jeffries R. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis. 2017 May;58:82-89. doi: 10.1016/j.ijid.2017.02.018. Epub 2017 Mar 1.

Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother. 2011 Jun;66(6):1215-22. doi: 10.1093/jac/dkr136. Epub 2011 Apr 11.

Ozaras R, Dilek A, Sunbul M, Leblebicioglu H. Association between Crimean-Congo hemorrhagic fever (CCHF) and coronavirus disease 2019 (COVID-19): A systematic review. Infect Control Hosp Epidemiol. 2022 Nov;43(11):1727-1728. doi: 10.1017/ice.2021.388. Epub 2021 Aug 31.

Bozkurt I, Erdeniz EH, Riley MJ, Şensoy L, Beeching NJ, Aydogdu S, Leblebicioglu H, Korukluoglu G, Fletcher TE. A Comparison of Clinical and Laboratory Features of Crimean-Congo Hemorrhagic Fever in Children and Adults: A Retrospective Single-Center Cohort Study and Literature Review. Vector Borne Zoonotic Dis. 2025 Feb;25(2):81-91. doi: 10.1089/vbz.2024.0066. Epub 2024 Sep 23.

Ozaras R, Leblebicioglu H. COVID-19 pandemic and international travel: Turkey's experience. Travel Med Infect Dis. 2021 Mar-Apr;40:101972. doi: 10.1016/j.tmaid.2021.101972. Epub 2021 Jan 13.

Leblebicioglu H, Ozaras R, Erciyas-Yavuz K. Emergence of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg. 2015 Nov;109(11):676-8. doi: 10.1093/trstmh/trv083.

D'Addiego J, Wand N, Afrough B, Fletcher T, Kurosaki Y, Leblebicioglu H, Hewson R. Recovery of complete genome sequences of Crimean-Congo haemorrhagic fever virus (CCHFV) directly from clinical samples: A comparative study between targeted enrichment and metagenomic approaches. J Virol Methods. 2024 Jan;323:114833. doi: 10.1016/j.jviromet.2023.114833. Epub 2023 Oct 23.

Sunbul M, Leblebicioglu H, Fletcher TE, Elaldi N, Ozkurt Z, Bastug A, Yilmaz G, Guner R, Duygu F, Beeching NJ. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015 Nov;71(5):597-9. doi: 10.1016/j.jinf.2015.07.003. Epub 2015 Jul 18.

Ozaras R, Leblebicioglu H. How to compare antivirals in the treatment of chronic hepatitis B? Ann Clin Microbiol Antimicrob. 2009 Mar 2;8:6. doi: 10.1186/1476-0711-8-6.

Leblebicioglu H, Sunbul M, Esen S, Eroglu C. Jarisch-Herxheimer reaction in leptospirosis. Eur J Clin Microbiol Infect Dis. 2003 Oct;22(10):639; author reply 640. doi: 10.1007/s10096-003-1011-6. Epub 2003 Sep 12.

Erdem H, Elaldi N, Öztoprak N, Sengoz G, Ak O, Kaya S, Inan A, Nayman-Alpat S, Ulu-Kilic A, Pekok AU, Gunduz A, Gozel MG, Pehlivanoglu F, Yasar K, Yılmaz H, Hatipoglu M, Cicek-Senturk G, Akcam FZ, Inkaya AC, Kazak E, Sagmak-Tartar A, Tekin R, Ozturk-Engin D, Ersoy Y, Sipahi OR, Guven T, Tuncer-Ertem G, Alabay S, Akbulut A, Balkan II, Oncul O, Cetin B, Dayan S, Ersoz G, Karakas A, Ozgunes N, Sener A, Yesilkaya A, Erturk A, Gundes S, Karabay O, Sirmatel F, Tosun S, Turhan V, Yalci A, Akkoyunlu Y, Aydın E, Diktas H, Kose S, Ulcay A, Seyman D, Savasci U, Leblebicioglu H, Vahaboglu H. Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis. 2014 Feb;19:13-9. doi: 10.1016/j.ijid.2013.09.012. Epub 2013 Oct 30.

Bozkurt I, Coksevim M, Cerik IB, Gulel O, Tanyel E, Leblebicioglu H. Infective endocarditis with atypical clinical feature and relapse by Abiotrophia defectiva. J Saudi Heart Assoc. 2017 Apr;29(2):136-138. doi: 10.1016/j.jsha.2016.06.003. Epub 2016 Jun 16.

Leblebicioglu H, Eroglu C, Erciyas-Yavuz K, Hokelek M, Acici M, Yilmaz H. Role of migratory birds in spreading Crimean-Congo hemorrhagic fever, Turkey. Emerg Infect Dis. 2014 Aug;20(8):1331-4. doi: 10.3201/eid2008.131547.

Leblebicioglu H. Antimicrobial treatment of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2004 May 15;169(10):1166; author reply 1166-7. doi: 10.1164/ajrccm.169.10.956.

Leblebicioglu H, Sencan I, Sünbül M, Altintop L, Günaydin M. Weil's disease: report of 12 cases. Scand J Infect Dis. 1996;28(6):637-9. doi: 10.3109/00365549609037976.

Leblebicioglu H, Sunbul M. Leptospiral infection and seropositivity in rodents. Prev Vet Med. 2004 Aug 30;65(1-2):117-8; author reply 119. doi: 10.1016/j.prevetmed.2004.06.003.

Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, Myatra SN, Afeef M, Tanzi VL, Muralidharan S, Al-Abdely HM, El-Kholy A, AlKhawaja SAA, Demiroz AP, Mehta Y, Rai V, Hung NV, Sayed AF, Salgado-Yepez E, Elahi N, Del Rayo Morfin-Otero M, Luxsuwong M, De-Carvalho BM, Tapang ARD, Velinova VA, Quesada-Mora AM, Anguseva T, Ikram A, Aguilar-de-Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di-Silvestre G, Furova K, Gamar-Elanbya MO, Gupta U, Abidi K, Raka L, Guo X, Jayatilleke K, Ben-Jaballah N, Sandoval-Castillo HR, Trotter A, Valderrama-Beltrán SL, Leblebicioglu H, Guanche-Garcell H, de Lourdes-Dueñas M. Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 727 intensive care units of 268 hospitals in 141 cities of 42 countries of Africa, the Americas, Eastern Mediterranean, Europe, South East Asia, and Western Pacific Regions: International Nosocomial Infection Control Consortium (INICC) findings. Infect Control Hosp Epidemiol. 2020 May;41(5):553-563. doi: 10.1017/ice.2020.20. Epub 2020 Mar 18.

Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID). Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries. Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.

Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, Elaldi N, Cicek Senturk G, Ozkurt Z, Yilmaz G, Fletcher TE, Beeching NJ. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016 Apr;22(4):387.e1-387.e4. doi: 10.1016/j.cmi.2015.11.024. Epub 2016 Jan 20.

Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, Myatra SN, Afeef M, Tanzi VL, Muralidharan S, Gurskis V, Al-Abdely HM, El-Kholy A, AlKhawaja SAA, Sen S, Mehta Y, Rai V, Hung NV, Sayed AF, Guerrero-Toapanta FM, Elahi N, Morfin-Otero MDR, Somabutr S, De-Carvalho BM, Magdarao MS, Velinova VA, Quesada-Mora AM, Anguseva T, Ikram A, Aguilar-de-Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di-Silvestre G, Furova K, Gamar-Elanbya MO, Gupta U, Abidi K, Raka L, Guo X, Luque-Torres MT, Jayatilleke K, Ben-Jaballah N, Gikas A, Sandoval-Castillo HR, Trotter A, Valderrama-Beltrán SL, Leblebicioglu H; International Nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control. 2020 Apr;48(4):423-432. doi: 10.1016/j.ajic.2019.08.023. Epub 2019 Oct 29.

Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SAA, Leblebicioglu H, Mehta Y, Rai V, Hung NV, Kanj SS, Salama MF, Salgado-Yepez E, Elahi N, Morfin Otero R, Apisarnthanarak A, De Carvalho BM, Ider BE, Fisher D, Buenaflor MCSG, Petrov MM, Quesada-Mora AM, Zand F, Gurskis V, Anguseva T, Ikram A, Aguilar de Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di Silvestre G, Furova K, Ramos-Ortiz GY, Gamar Elanbya MO, Satari HI, Gupta U, Dendane T, Raka L, Guanche-Garcell H, Hu B, Padgett D, Jayatilleke K, Ben Jaballah N, Apostolopoulou E, Prudencio Leon WE, Sepulveda-Chavez A, Telechea HM, Trotter A, Alvarez-Moreno C, Kushner-Davalos L; Remaining authors. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module. Am J Infect Control. 2016 Dec 1;44(12):1495-1504. doi: 10.1016/j.ajic.2016.08.007. Epub 2016 Oct 11.

Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study. Pathog Glob Health. 2016 Oct-Dec;110(7-8):321-325. doi: 10.1080/20477724.2016.1254976. Epub 2016 Dec 1.

Tanyel E, Sunbul M, Fletcher TE, Leblebicioglu H. Aetiology of PCR negative suspected Crimean-Congo hemorrhagic fever cases in an endemic area. Pathog Glob Health. 2016 Jun-Jul;110(4-5):173-7. doi: 10.1080/20477724.2016.1213958.

Canbaz S, Peksen Y, Tevfik Sunter A, Leblebicioglu H, Sunbul M. Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents. 2002 Dec;20(6):407-11. doi: 10.1016/s0924-8579(02)00252-2.

Ozaras R, Cirpin R, Duman H, Duran A, Arslan O, Leblebicioglu H. An open call for influenza vaccination pending the new wave of COVID-19. J Med Virol. 2021 Jan;93(1):172-173. doi: 10.1002/jmv.26272. Epub 2020 Jul 14.

Leblebicioglu H, Turan D, Eroglu C, Esen S, Sunbul M, Bostanci F. A cluster of anthrax cases including meningitis. Trop Doct. 2006 Jan;36(1):51-3. doi: 10.1258/004947506775598798.

Aker S, Akıncı H, Kılıçoğlu C, Leblebicioglu H. The geographic distribution of cases of Crimean-Congo hemorrhagic fever: Kastamonu, Turkey. Ticks Tick Borne Dis. 2015 Sep;6(6):730-6. doi: 10.1016/j.ttbdis.2015.06.008. Epub 2015 Jun 22.

Yilmaz H, Turhan V, Yasar KK, Hatipoglu M, Sunbul M, Leblebicioglu H. Characteristics of leptospirosis with systemic inflammatory response syndrome: a multicenter study. Ann Clin Microbiol Antimicrob. 2015 Dec 21;14:54. doi: 10.1186/s12941-015-0117-x.

Leblebicioglu H, Cakir N, Celen M, Kurt H, Baris H, Laeuffer J; Turkish COMPACT Study Group. Comparative activity of carbapenem testing (the COMPACT study) in Turkey. BMC Infect Dis. 2012 Feb 16;12:42. doi: 10.1186/1471-2334-12-42.

Erdem H, Dizbay M, Karabey S, Kaya S, Demirdal T, Koksal I, Inan A, Erayman I, Ak O, Ulu-Kilic A, Karasahin O, Akbulut A, Elaldi N, Yilmaz G, Candevir A, Gul HC, Gonen I, Oncul O, Aslan T, Azak E, Tekin R, Kocak Tufan Z, Yenilmez E, Arda B, Gungor G, Cetin B, Kose S, Turan H, Akalin H, Karabay O, Dogan-Celik A, Albayrak A, Guven T, Celebi G, Ozgunes N, Ersoy Y, Sirmatel F, Oztoprak N, Balkan II, Bayazit FN, Ucmak H, Oncu S, Ozdemir D, Ozturk-Engin D, Bitirgen M, Tabak F, Akata F, Willke A, Gorenek L, Ahmed SS, Tasova Y, Ulcay A, Dayan S, Esen S, Leblebicioglu H, Altun B, Unal S. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control. 2013 Nov;41(11):1053-8. doi: 10.1016/j.ajic.2013.01.041. Epub 2013 May 8.

Sunbul M, Esen S, Fletcher TE, Dilek A, Guler N, Beeching NJ, Leblebicioglu H. A fatal case of healthcare associated Crimean-Congo haemorrhagic fever with severe disease and multi-organ failure. J Infect. 2016 Feb;72(2):253-5. doi: 10.1016/j.jinf.2015.10.005. Epub 2015 Oct 19.

Leblebicioglu H, Sunbul M, Barut S, Buyuktuna SA, Ozkurt Z, Yapar D, Yilmaz G, Guner R, But A, Cicek Senturk G, Murat N, Ozaras R; Crimean Congo Hemorrhagic Fever Research Network of Turkey. Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever. Antiviral Res. 2016 Sep;133:9-13. doi: 10.1016/j.antiviral.2016.07.010. Epub 2016 Jul 15.

Sunbul M, Atilla A, Esen S, Eroglu C, Leblebicioglu H. Thwaites' diagnostic scoring and the prediction of tuberculous meningitis. Med Princ Pract. 2005 May-Jun;14(3):151-4. doi: 10.1159/000084631.

Fletcher TE, Leblebicioglu H, Bozkurt I, Sunbul M, Bilek H, Asik Z, Barut S, Gunes F, Gemici U, Hewson R, Wilson D, O'Shea MK, Woolley T, Faragher B, Parmar K, Lalloo DG, Beeching NJ, Hunt BJ. Rotational thromboelastometry alongside conventional coagulation testing in patients with Crimean-Congo haemorrhagic fever: an observational cohort study. Lancet Infect Dis. 2019 Aug;19(8):862-871. doi: 10.1016/S1473-3099(19)30112-4. Epub 2019 Jun 28.

Sünbül M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects. Scand J Infect Dis. 2000;32(3):315-6. doi: 10.1080/00365540050165983.

Willke A, Arman D, Cokça F, Sümerkan B, Söyletir G, Bakir M, Sirmatel F, Leblebicioğlu H, Kijlijç S. Resistance of Salmonella and Shigella in Turkey. Clin Microbiol Infect. 1999 Sep;5(9):588-590. doi: 10.1111/j.1469-0691.1999.tb00443.x.

Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, Kocazeybek B, Tatman-Otkun M, Leblebicioglu H, Ozinel MA, Akalin H, Kocagoz S, Korten V. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol. 2001 Jul;50(7):642-645. doi: 10.1099/0022-1317-50-7-642.

Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly. 2004 Jun 12;134(23-24):347-52. doi: 10.4414/smw.2004.10436.

Rosenthal VD, Belkebir S, Zand F, Afeef M, Tanzi VL, Al-Abdely HM, El-Kholy A, Aziz AlKhawaja SA, Demiroz AP, Sayed AF, Elahi N, Gamar-Elanbya MO, Abidi K, Ben-Jaballah N, Salama MF, Helali NJ, Abdel-Halim MM, Demaisip NL, Ahmed H, Diab HH, Molano AM, Sawan FA, Kelany A, Altowerqi R, Rushdi H, Alkamaly MA, Bohlega E, Aldossary HA, Abdelhady KM, Ikram A, Madco M, Caminade Y, Alazmi M, Mahfouz T, Abdelaziz-Yousef RH, Ibrahim A, Elawady B, Asad T, Shyrine L, Leblebicioglu H. Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 246 intensive units of 83 hospitals in 52 cities of 14 countries of Middle East: Bahrain, Egypt, Iran, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Morocco, Pakistan, Palestine, Sudan, Tunisia, Turkey, and United Arab Emirates-International Nosocomial Infection Control Consortium (INICC) findings. J Infect Public Health. 2020 Aug;13(8):1134-1141. doi: 10.1016/j.jiph.2020.03.012. Epub 2020 Apr 12.

Yilmaz M, Elaldi N, Balkan İİ, Arslan F, Batırel AA, Bakıcı MZ, Gozel MG, Alkan S, Çelik AD, Yetkin MA, Bodur H, Sınırtaş M, Akalın H, Altay FA, Şencan İ, Azak E, Gündeş S, Ceylan B, Öztürk R, Leblebicioglu H, Vahaboglu H, Mert A. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann Clin Microbiol Antimicrob. 2016 Feb 9;15:7. doi: 10.1186/s12941-016-0122-8.

Leblebicioglu H, Esen S, Turan D, Tanyeri Y, Karadenizli A, Ziyagil F, Goral G. Outbreak of tularemia: a case-control study and environmental investigation in Turkey. Int J Infect Dis. 2008 May;12(3):265-9. doi: 10.1016/j.ijid.2007.06.013. Epub 2007 Nov 5.

Cengiz K, Sahan C, Sünbül M, Leblebicioğlu H, Cüner E. Acute renal failure in leptospirosis in the black-sea region in Turkey. Int Urol Nephrol. 2002;33(1):133-6. doi: 10.1023/a:1014494012062.

Tanyel E, Sunbul M, Fletcher T, Leblebicioglu H. A case of endocarditis mimicking Crimean-Congo haemorrhagic fever. Trop Doct. 2017 Jan;47(1):71-72. doi: 10.1177/0049475516660465. Epub 2016 Aug 2.

Erdem H, Turkan H, Cilli A, Karakas A, Karakurt Z, Bilge U, Yazicioglu-Mocin O, Elaldi N, Adıguzel N, Gungor G, Taşcı C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Tomak Y, Inan A, Karaboğa B, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozcengiz D, Turker T, Afyon M, Samur AA, Ulcay A, Savasci U, Diktas H, Ozgen-Alpaydın A, Kilic E, Bilgic H, Leblebicioglu H, Unal S, Sonmez G, Gorenek L. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey. Int J Infect Dis. 2013 Sep;17(9):e768-72. doi: 10.1016/j.ijid.2013.03.015. Epub 2013 May 9.

Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader Ç, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One. 2017 Sep 8;12(9):e0182315. doi: 10.1371/journal.pone.0182315. eCollection 2017.

Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F, Willke A, Sirmatel F, Oztoprak N, Koksal I, Oncul O, Gurbuz Y, Güçlü E, Turgut H, Yalcin AN, Ozdemir D, Kendirli T, Aslan T, Esen S, Ulger F, Dilek A, Yilmaz H, Sunbul M, Ozgunes I, Usluer G, Otkun M, Kaya A, Kuyucu N, Kaya Z, Meric M, Azak E, Yýlmaz G, Kaya S, Ulusoy H, Haznedaroglu T, Gorenek L, Acar A, Tutuncu E, Karabay O, Kaya G, Sacar S, Sungurtekin H, Uğurcan D, Turhan O, Kaya S, Gumus E, Dursun O, Geyik MF, Şahin A, Erdogan S, Ince E, Karbuz A, Çiftçi E, Taşyapar N, Güneş M. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2015 Jan;43(1):48-52. doi: 10.1016/j.ajic.2014.09.017.

Leblebicioglu H, Yilmaz H, Tasova Y, Alp E, Saba R, Caylan R, Bakir M, Akbulut A, Arda B, Esen S. Characteristics and analysis of risk factors for mortality in infective endocarditis. Eur J Epidemiol. 2006;21(1):25-31. doi: 10.1007/s10654-005-4724-2.

Ulger F, Esen S, Dilek A, Yanik K, Gunaydin M, Leblebicioglu H. Are we aware how contaminated our mobile phones with nosocomial pathogens? Ann Clin Microbiol Antimicrob. 2009 Mar 6;8:7. doi: 10.1186/1476-0711-8-7.

Leblebicioglu H, Sunbul M, Bodur H, Ozaras R; Crimean–Congo Haemorrhagic Fever Research Network of Turkey (CCRNT). Discharge criteria for Crimean-Congo haemorrhagic fever in endemic areas. J Infect. 2016 Apr;72(4):500-1. doi: 10.1016/j.jinf.2016.01.009. Epub 2016 Jan 29.

Guler N, Eroglu C, Yilmaz H, Karadag A, Alacam H, Sunbul M, Fletcher TE, Leblebicioglu H. Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever. PLoS One. 2016 Jun 15;11(6):e0157247. doi: 10.1371/journal.pone.0157247. eCollection 2016.

Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H; International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006 Oct 17;145(8):582-91. doi: 10.7326/0003-4819-145-8-200610170-00007.

Sunbul M, Demirag MK, Yilmaz O, Yilmaz H, Ozturk R, Leblebicioglu H. Pacemaker lead endocarditis caused by Staphylococcus hominis. Pacing Clin Electrophysiol. 2006 May;29(5):543-5. doi: 10.1111/j.1540-8159.2006.00391.x.

Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, Leblebicioglu H, Fisher D, Álvarez-Moreno C, Khader IA, Del Rocío González Martínez M, Cuellar LE, Navoa-Ng JA, Abouqal R, Guanche Garcell H, Mitrev Z, Pirez García MC, Hamdi A, Dueñas L, Cancel E, Gurskis V, Rasslan O, Ahmed A, Kanj SS, Ugalde OC, Mapp T, Raka L, Yuet Meng C, Thu le TA, Ghazal S, Gikas A, Narváez LP, Mejía N, Hadjieva N, Gamar Elanbya MO, Guzmán Siritt ME, Jayatilleke K; INICC members. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control. 2012 Jun;40(5):396-407. doi: 10.1016/j.ajic.2011.05.020. Epub 2011 Sep 10.

Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramírez Wong FM, Barkat A, Pino OR, Dueñas L, Mitrev Z, Bijie H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu le TA, Guzmán Siritt ME; INICC Members. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010 Mar;38(2):95-104.e2. doi: 10.1016/j.ajic.2009.12.004.

Sunbul M, Leblebicioglu H. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. World J Gastroenterol. 2005 Apr 7;11(13):1976-80. doi: 10.3748/wjg.v11.i13.1976.

Canbaz S, Sunter AT, Peksen Y, Leblebicioglu H. Survey of general practitioners' knowledge about Helicobacter pylori infection. BMC Gastroenterol. 2005 Jan 26;5:4. doi: 10.1186/1471-230X-5-4.

Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-Kilic A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, Demirdal T, Elaldi N, Ataman-Hatipoglu C, Yilmaz E, Mete B, Kurtaran B, Ceran N, Karabay O, Inan D, Cengiz M, Sacar S, Yucesoy-Dede B, Yilmaz S, Agalar C, Bayindir Y, Alpay Y, Tosun S, Yilmaz H, Bodur H, Erdem HA, Dikici N, Dizbay M, Oncu S, Sezak N, Sari T, Sipahi OR, Uysal S, Yeniiz E, Kaya S, Ulcay A, Kurt H, Besirbellioglu BA, Vahaboglu H, Tasova Y, Usluer G, Arman D, Diktas H, Ulusoy S, Leblebicioglu H. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob. 2011 Dec 16;10:38. doi: 10.1186/1476-0711-10-38.

Leblebicioglu H, Ersoz G, Rosenthal VD, Yalcin AN, Akan OA, Sirmatel F, Turgut H, Ozdemir D, Alp E, Uzun C, Ulusoy S, Esen S, Ulger F, Dilek A, Yilmaz H, Kaya A, Kuyucu N, Turhan O, Gunay N, Gumus E, Dursun O, Tulunay M, Oral M, Unal N, Cengiz M, Yilmaz L, Sacar S, Sungurtekin H, Uğurcan D, Geyik MF, Sahin A, Erdogan S, Aygen B, Arda B, Bacakoglu F. Impact of a multidimensional infection control approach on catheter-associated urinary tract infection rates in adult intensive care units in 10 cities of Turkey: International Nosocomial Infection Control Consortium findings (INICC). Am J Infect Control. 2013 Oct;41(10):885-91. doi: 10.1016/j.ajic.2013.01.028. Epub 2013 Apr 23.

Leblebicioglu H, Ozaras R, Sunbul M. Crimean-Congo hemorrhagic fever: A neglected infectious disease with potential nosocomial infection threat. Am J Infect Control. 2017 Jul 1;45(7):815-816. doi: 10.1016/j.ajic.2016.05.039. Epub 2017 Apr 11.

Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, Mert G, Tekin-Koruk S, Dizbay M, Inal AS, Nayman-Alpat S, Bosilkovski M, Inan D, Saltoglu N, Abdel-Baky L, Adeva-Bartolome MT, Ceylan B, Sacar S, Turhan V, Yilmaz E, Elaldi N, Kocak-Tufan Z, Ugurlu K, Dokuzoguz B, Yilmaz H, Gundes S, Guner R, Ozgunes N, Ulcay A, Unal S, Dayan S, Gorenek L, Karakas A, Tasova Y, Usluer G, Bayindir Y, Kurtaran B, Sipahi OR, Leblebicioglu H. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012 Mar;56(3):1523-8. doi: 10.1128/AAC.05974-11. Epub 2011 Dec 12.

Turgut M, Sünbül M, Bayirli D, Bilge A, Leblebicioğlu H, Haznedaroğlu I. Thrombocytopenia complicating the clinical course of leptospiral infection. J Int Med Res. 2002 Sep-Oct;30(5):535-40. doi: 10.1177/147323000203000511.

Leblebicioglu H, Eroglu C; Members of the Hepatitis Study Group. Acute hepatitis B virus infection in Turkey: epidemiology and genotype distribution. Clin Microbiol Infect. 2004 Jun;10(6):537-41. doi: 10.1111/j.1469-0691.2004.00871.x.

Arama V, Leblebicioglu H, Simon K, Zarski JP, Niederau C, Habersetzer F, Vermehren J, Bludzin W, Jinga M, Ulusoy S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zeuzem S; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies. Antivir Ther. 2014;19(3):245-57. doi: 10.3851/IMP2719. Epub 2013 Dec 17.

Sunbul M, Esen S, Leblebicioglu H, Hokelek M, Pekbay A, Eroglu C. Rattus norvegicus acting as reservoir of leptospira interrogans in the Middle Black Sea region of Turkey, as evidenced by PCR and presence of serum antibodies to Leptospira strain. Scand J Infect Dis. 2001;33(12):896-8. doi: 10.1080/00365540110076796.

Rosenthal VD, Pawar M, Leblebicioglu H, Navoa-Ng JA, Villamil-Gómez W, Armas-Ruiz A, Cuéllar LE, Medeiros EA, Mitrev Z, Gikas A, Yang Y, Ahmed A, Kanj SS, Dueñas L, Gurskis V, Mapp T, Guanche-Garcell H, Fernández-Hidalgo R, Kübler A. Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional hand hygiene approach over 13 years in 51 cities of 19 limited-resource countries from Latin America, Asia, the Middle East, and Europe. Infect Control Hosp Epidemiol. 2013 Apr;34(4):415-23. doi: 10.1086/669860. Epub 2013 Feb 14.

Leblebicioglu H, Ozaras R, Sunbul M. Role of co-trimoxazole for urinary tract infections in developing countries. Lancet Infect Dis. 2015 Jul;15(7):764-5. doi: 10.1016/S1473-3099(15)00076-6.

Leblebicioglu H, Koksal I, Rosenthal VD, Akan ÖA, Özgültekin A, Kendirli T, Erben N, Yalcin AN, Ulusoy S, Sirmatel F, Ozdemir D, Alp E, Yıldızdaş D, Esen S, Ulger F, Dilek A, Yilmaz H, Yýlmaz G, Kaya S, Ulusoy H, Tulunay M, Oral M, Ünal N, Turan G, Akgün N, İnan A, Ince E, Karbuz A, Çiftçi E, Taşyapar N, Güneş M, Ozgunes I, Usluer G, Turhan O, Gunay N, Gumus E, Dursun O, Arda B, Bacakoglu F, Cengiz M, Yilmaz L, Geyik MF, Şahin A, Erdogan S, Kılıc AU, Horoz OO. Impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Hand Hygiene Approach, over 8 years, in 11 cities of Turkey. J Infect Prev. 2015 Jul;16(4):146-154. doi: 10.1177/1757177414560249. Epub 2014 Dec 10.

Leblebicioglu H, Sencan I, Gunaydin M, Esen S, Eroglu C, Sunbul M. Elution of vancomycin and tobramycin bonded to vascular grafts. J Chemother. 1999 Feb;11(1):46-9. doi: 10.1179/joc.1999.11.1.46.

Erdem H, Kocak-Tufan Z, Yilmaz O, Karakurt Z, Cilli A, Turkan H, Yazicioglu-Mocin O, Adıguzel N, Gungor G, Taşcı C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Tomak Y, Inan A, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozturk-Engin D, Ozcengiz D, Karakas A, Bilgic H, Leblebicioglu H. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: a multicentre retrospective study. Ann Clin Microbiol Antimicrob. 2014 Jan 8;13:5. doi: 10.1186/1476-0711-13-5.

Günseren F, Mamikoğlu L, Oztürk S, Yücesoy M, Biberoğlu K, Yuluğ N, Doğanay M, Sümerkan B, Kocagöz S, Unal S, Cetin S, Calangu S, Köksal I, Leblebicioğlu H, Günaydin M. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother. 1999 Mar;43(3):373-8. doi: 10.1093/jac/43.3.373.

Erdem H, Inan A, Altındis S, Carevic B, Askarian M, Cottle L, Beovic B, Csomos A, Metodiev K, Ahmetagic S, Harxhi A, Raka L, Grozdanovski K, Nechifor M, Alp E, Bozkurt F, Hosoglu S, Balik I, Yilmaz G, Jereb M, Moradi F, Petrov N, Kaya S, Koksal I, Aslan T, Elaldi N, Akkoyunlu Y, Moravveji SA, Csato G, Szedlak B, Akata F, Oncu S, Grgic S, Cosic G, Stefanov C, Farrokhnia M, Müller M, Luca C, Koluder N, Korten V, Platikanov V, Ivanova P, Soltanipour S, Vakili M, Farahangiz S, Afkhamzadeh A, Beeching N, Ahmed SS, Cami A, Shiraly R, Jazbec A, Mirkovic T, Leblebicioglu H, Naber K. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran--a prospective multicenter point prevalence study. J Infect. 2014 Feb;68(2):131-40. doi: 10.1016/j.jinf.2013.11.001. Epub 2013 Nov 20.

Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik MA, Dokuzoguz B, Tasyaran MA, Ozturk R, Bakir M, Uzun R. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect. 2009 Mar;58(3):238-44. doi: 10.1016/j.jinf.2009.01.014. Epub 2009 Feb 26.

Sencan I, Sahin I, Tuzuner T, Ozdemir D, Yildirim M, Leblebicioglu H. In vitro bacterial adherence to teicoplanin and calcium sulfate-soaked bone cement. J Chemother. 2005 Apr;17(2):174-8. doi: 10.1179/joc.2005.17.2.174.

Bozkurt I, Sunbul M, Yilmaz H, Esen S, Leblebicioglu H, Beeching NJ. Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system. Pathog Glob Health. 2016;110(1):9-13. doi: 10.1080/20477724.2015.1136130. Epub 2016 Feb 25.

Leblebicioglu H, Öztürk R, Rosenthal VD, Akan ÖA, Sirmatel F, Ozdemir D, Uzun C, Turgut H, Ersoz G, Koksal I, Özgültekin A, Esen S, Ulger F, Dilek A, Yilmaz H, Dikmen Y, Aygún G, Tulunay M, Oral M, Ünal N, Cengiz M, Yilmaz L, Geyik MF, Şahin A, Erdogan S, Sacar S, Sungurtekin H, Uğurcan D, Kaya A, Kuyucu N, Yýlmaz G, Kaya S, Ulusoy H, İnan A. Impact of a multidimensional infection control approach on central line-associated bloodstream infections rates in adult intensive care units of 8 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Ann Clin Microbiol Antimicrob. 2013 May 4;12:10. doi: 10.1186/1476-0711-12-10.

Leblebicioglu H, Nas Y, Eroglu C, Sunbul M, Esen S, Gunaydin M. Detection of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Chemother. 1999 Apr;11(2):103-6. doi: 10.1179/joc.1999.11.2.103.

Rosenthal VD, Maki DG, Rodrigues C, Alvarez-Moreno C, Leblebicioglu H, Sobreyra-Oropeza M, Berba R, Madani N, Medeiros EA, Cuéllar LE, Mitrev Z, Dueñas L, Guanche-Garcell H, Mapp T, Kanj SS, Fernández-Hidalgo R; International Nosocomial Infection Control Consortium Investigators. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries. Infect Control Hosp Epidemiol. 2010 Dec;31(12):1264-72. doi: 10.1086/657140. Epub 2010 Oct 28.

Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zarski JP; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries. J Viral Hepat. 2014;21(9):662-70. doi: 10.1111/jvh.12202. Epub 2013 Dec 15.

Leblebicioglu H, Erben N, Rosenthal VD, Atasay B, Erbay A, Unal S, Senol G, Willke A, Özgültekin A, Altin N, Bakir M, Oncul O, Ersöz G, Ozdemir D, Yalcin AN, Özdemir H, Yıldızdaş D, Koksal I, Aygun C, Sirmatel F, Sener A, Tuna N, Akan ÖA, Turgut H, Demiroz AP, Kendirli T, Alp E, Uzun C, Ulusoy S, Arman D. International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012. Ann Clin Microbiol Antimicrob. 2014 Nov 18;13:51. doi: 10.1186/s12941-014-0051-3.

Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH, Balkhy H, Hu B, Alvarez-Moreno C, Medeiros EA, Apisarnthanarak A, Raka L, Cuellar LE, Ahmed A, Navoa-Ng JA, El-Kholy AA, Kanj SS, Bat-Erdene I, Duszynska W, Van Truong N, Pazmino LN, See-Lum LC, Fernández-Hidalgo R, Di-Silvestre G, Zand F, Hlinkova S, Belskiy V, Al-Rahma H, Luque-Torres MT, Bayraktar N, Mitrev Z, Gurskis V, Fisher D, Abu-Khader IB, Berechid K, Rodríguez-Sánchez A, Horhat FG, Requejo-Pino O, Hadjieva N, Ben-Jaballah N, García-Mayorca E, Kushner-Dávalos L, Pasic S, Pedrozo-Ortiz LE, Apostolopoulou E, Mejía N, Gamar-Elanbya MO, Jayatilleke K, de Lourdes-Dueñas M, Aguirre-Avalos G; International Nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. Am J Infect Control. 2014 Sep;42(9):942-56. doi: 10.1016/j.ajic.2014.05.029.

Leblebicioğlu H, Esen S, Bedir A, Günaydin M, Saniç A. The validity of Spanos' and Hoen's models for differential diagnosis of meningitis. Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):252-4. doi: 10.1007/BF01591365.

Bozkurt İ, Unver T, Sunbul M, Leblebicioglu H. Bacterial and Fungal Infections in the Early Post-Transplant Period After Kidney Transplantation: Etiological Agents and Their Susceptibility. Transplant Proc. 2015 Oct;47(8):2554. doi: 10.1016/j.transproceed.2015.08.016.

Leblebicioglu H. Ribavirin treatment for Crimean-Congo hemorrhagic fever. Jpn J Infect Dis. 2009 Nov;62(6):485-6; author reply 486.

Leblebicioğlu H, Günaydin M, Cengiz K, Işlek I. [Hepatitis markers in hemodialysis patients]. Mikrobiyol Bul. 1993 Oct;27(4):321-6.

Tanyel E, Taşdelen Fişgin N, Esen S, Darka O, Bahçivan M, Leblebicioğlu H, Tülek N. [A rare case of endocarditis due to Moraxella catarrhalis in an immunocompetent patient]. Mikrobiyol Bul. 2009 Oct;43(4):667-70.

Tanyel E, Tasdelen Fisgin N, Yildiz L, Leblebicioglu H, Doganci L, Tulek N. Panniculitis as the initial manifestation of brucellosis: a case report. Am J Dermatopathol. 2008 Apr;30(2):169-71. doi: 10.1097/DAD.0b013e31816563f5.

Usluer G, Ozgunes I, Leblebicioglu H; Turkish Antibiotic Utilization Study Group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005 Oct 3;4:16. doi: 10.1186/1476-0711-4-16.

Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, Ramírez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Dueñas L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mejía N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C; International Nosocomial Infection Control Consortiuma. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086/670626. Epub 2013 Apr 18.

Leblebicioglu H, Saniç A, Günaydin M, Sencan I, Dabak N, Nas Y. In-vitro release of vancomycin and netilmicin from bone cement. Clin Microbiol Infect. 1996 Mar;1(3):211-212. doi: 10.1111/j.1469-0691.1996.tb00559.x.

Leblebicioglu H, Canbaz S, Peksen Y, Gunaydin M. Physicians' antibiotic prescribing habits for upper respiratory tract infections in Turkey. J Chemother. 2002 Apr;14(2):181-4. doi: 10.1179/joc.2002.14.2.181.

Leblebicioğlu H, Günaydin M, Durupinar B. [Hepatitis b seroprevalence in hospital personnel]. Mikrobiyol Bul. 1993 Apr;27(2):113-8.

Eroglu C, Leblebicioglu H, Gunaydin M, Turan D, Sunbul M, Esen S, Sanic A. Distinguishing hepatitis B virus (HBV) genotype D from non-D by a simple PCR. J Virol Methods. 2004 Aug;119(2):183-7. doi: 10.1016/j.jviromet.2004.03.003.

Marcellin P, Arama V, Leblebicioglu H, Zarski JP, Zeuzem S, Mauss S, Sieklucki J, Acalovschi M, Usluer G, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Simon K; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study. Antivir Ther. 2014;19(3):235-43. doi: 10.3851/IMP2573. Epub 2013 Apr 10.

Aksaray Sg, Dokuzoguz B, Guvener E, Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S, Gunaydin M, Leblebicioglu H, Esen S, Bayar B, Willke A, Findik D, Tuncer I I, Baysal B, Gunseren F, Mamikoglu L. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in turkey. J Antimicrob Chemother. 2000 Oct;46(4):649. doi: 10.1093/oxfordjournals.jac.a020883.

Leblebicioglu H, Yalcin AN, Rosenthal VD, Koksal I, Sirmatel F, Unal S, Turgut H, Ozdemir D, Ersoz G, Uzun C, Ulusoy S, Esen S, Ulger F, Dilek A, Yilmaz H, Turhan O, Gunay N, Gumus E, Dursun O, Yýlmaz G, Kaya S, Ulusoy H, Cengiz M, Yilmaz L, Yildirim G, Topeli A, Sacar S, Sungurtekin H, Uğurcan D, Geyik MF, Şahin A, Erdogan S, Kaya A, Kuyucu N, Arda B, Bacakoglu F. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 11 adult intensive care units from 10 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Infection. 2013 Apr;41(2):447-56. doi: 10.1007/s15010-013-0407-1. Epub 2013 Jan 26.

Tasdelen Fisgin N, Aliyazicioglu Y, Tanyel E, Coban AY, Ulger F, Zivalioglu M, Esen S, Leblebicioglu H. The value of neopterin and procalcitonin in patients with sepsis. South Med J. 2010 Mar;103(3):216-9. doi: 10.1097/SMJ.0b013e3181cf11a1.

Esen S, Leblebicioglu H, Sunbul M, Eroglu C. Repeated relapses in a meropenem-treated Pseudomonas aeruginosa meningitis. J Chemother. 2002 Oct;14(5):535-6. doi: 10.1179/joc.2002.14.5.535.

Ozaras R, Corti G, Ruta S, Lacombe K, Mondelli MU, Irwing WL, Puoti M, Khalighi A, Santos ML, Harxhi A, Lazarevic I, Soriano V, Gervain J, Leblebicioglu H, Salmon D, Arends JE; ESCMID Study Group for Viral Hepatitis. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe. Clin Microbiol Infect. 2015 Nov;21(11):1027-32. doi: 10.1016/j.cmi.2015.07.002. Epub 2015 Jul 10.

Leblebicioglu H, Akbulut A, Ulusoy S, Sunbul M, Aydin K, Geyik MF, Esen S, Eroglu C. Informal consultations in infectious diseases and clinical microbiology practice. Clin Microbiol Infect. 2003 Jul;9(7):724-6. doi: 10.1046/j.1469-0691.2003.00584.x.

Gungor B, Esen S, Gök A, Yılmaz H, Malazgirt Z, Leblebicioğlu H. Comparison of the adherence of E.Coli and S. Aureus to ten different prosthetic mesh grafts: In vitro experimental study. Indian J Surg. 2010 Jun;72(3):226-31. doi: 10.1007/s12262-010-0061-0. Epub 2010 Aug 26.

Leblebicioglu H, Turan D, Sunbul M, Esen S, Eroglu C. Transmission of human immunodeficiency virus and hepatitis B virus by blood brotherhood rituals. Scand J Infect Dis. 2003;35(3):210. doi: 10.1080/0036554021000027012.

Sunbul M, Khan A, Kurbanov F, Leblebicioglu H, Sugiyama M, Tanaka Y, Mizokami M. Tracing the spread of hepatitis C virus in Turkey: a phylogenetic analysis. Intervirology. 2013;56(3):201-5. doi: 10.1159/000346775. Epub 2013 Mar 19.

Eroglu C, Zivalioglu M, Esen S, Sunbul M, Leblebicioglu H. Detection of hepatitis B virus in used razor blades by PCR. Hepat Mon. 2010 Winter;10(1):22-5. Epub 2010 Mar 1.

Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis. 2004;36(2):144-8. doi: 10.1080/00365540410019156.

Leblebicioglu H, Esen S; Turkish Nosocomial Urinary Tract Infection Study Group. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study. J Hosp Infect. 2003 Mar;53(3):207-10. doi: 10.1053/jhin.2002.1362.

Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, Cuellar LE, Madani N, Mitrev Z, Dueñas L, Navoa-Ng JA, Garcell HG, Raka L, Hidalgo RF, Medeiros EA, Kanj SS, Abubakar S, Nercelles P, Pratesi RD; International Nosocomial Infection Control Consortium Members. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control. 2008 Nov;36(9):627-37. doi: 10.1016/j.ajic.2008.03.003. Epub 2008 Oct 3.

Peksen Y, Canbaz S, Leblebicioglu H, Sunbul M, Esen S, Sunter AT. Primary care physicians' approach to diagnosis and treatment of hepatitis B and hepatitis C patients. BMC Gastroenterol. 2004 Feb 6;4:3. doi: 10.1186/1471-230X-4-3.

Karabay O, Leblebicioglu H. Interferon-beta, prednisolone and lamivudine combination in acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res. 2014 May;44(5):593. doi: 10.1111/hepr.12154.

Leblebicioglu H. Clinical aspects of chronic hepatitis C infection. JAMA. 2003 Sep 17;290(11):1453; author reply 1453-4. doi: 10.1001/jama.290.11.1453-b.

Ozaras R, Sunbul M, Parlak M, Bodur H, Leblebicioglu H. Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe. Hepatology. 2016 Nov;64(5):1825-1827. doi: 10.1002/hep.28592. Epub 2016 May 24.

Leblebicioglu H. Ref.: Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo. 2003 Jul-Aug;45(4):237; author reply 238. doi: 10.1590/s0036-46652003000400013. Epub 2003 Sep 17.

Yılmaz H, Mutlu Yılmaz E, Esen S, Sünbül M, Leblebicioğlu H. [Treatment of hemodialysis catheter-associated bacteremia due to methicillin-resistant Staphylococcus aureus by daptomycin lock method]. Mikrobiyol Bul. 2012 Jul;46(3):470-4.

Sunbul M, Sugiyama M, Kurbanov F, Leblebicioglu H, Khan A, Elkady A, Tanaka Y, Mizokami M. Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey. Microbiol Immunol. 2013 Feb;57(2):122-9. doi: 10.1111/1348-0421.12011.

Tasdelen Fisgin N, Aydin BK, Sarikaya H, Tanyel E, Esen S, Sunbul M, Leblebicioglu H. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin Lab. 2012;58(3-4):273-80.

Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgültekin A, Yalcin AN, Koksal I, Usluer G, Sardan YC, Ulusoy S; Turkish Branch of INICC. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007 Mar;65(3):251-7. doi: 10.1016/j.jhin.2006.10.012. Epub 2007 Jan 25.

Vahaboglu H, Oztürk R, Aygün G, Coşkunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Otkun M. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother. 1997 Oct;41(10):2265-9. doi: 10.1128/AAC.41.10.2265.

Leblebicioglu H, Gunaydin M, Esen S, Tuncer I, Findik D, Ural O, Saltoslu N, Yaman A, Tasova Y; Study Group. Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey: analysis of data from the last 5 years. J Chemother. 2002 Apr;14(2):140-6. doi: 10.1179/joc.2002.14.2.140.

Leblebicioglu H, Unal S. The organization of hospital infection control in Turkey. J Hosp Infect. 2002 May;51(1):1-6. doi: 10.1053/jhin.2002.1195.

Leblebicioglu H. Enterohemorrhagic Escherichia coli epidemic: the sensitive role of the media in the handling of epidemics. Clin Infect Dis. 2012 Feb 1;54(3):450-1. doi: 10.1093/cid/cir719. Epub 2011 Oct 25.

Kocamanoğlu IS, Sarihasan B, Sener B, Leblebicioğlu H, Tür A, Kaya C, Bilgin S. [Seroprevalence of hepatitis B and C infections in surgical personnel and evaluation of predisposing factors]. Mikrobiyol Bul. 2003 Oct;37(4):285-95.

Demirag MK, Esen S, Zivalioglu M, Leblebicioglu H, Keceligil HT. The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts. Ann Vasc Surg. 2007 Jul;21(4):464-7. doi: 10.1016/j.avsg.2006.06.006. Epub 2007 Feb 14.

Karadenizli A, Kolayli F, Okay E, Ergen K, Oz S, Savli H, Leblebicioglu H, Vahaboglu H. Resistance emergence among P. aenrginosa in a rat thigh-abscess model. Comparison of imipenem and meropenem treatment. New Microbiol. 2003 Jul;26(3):275-80.

Ozaras R, Leblebicioglu H, Eroglu C. To define virological response in hepatitis B e antigen-negative patients. Hepatology. 2008 Apr;47(4):1425; author reply 1425-6. doi: 10.1002/hep.22233.

Sunbul M, Leblebicioglu H, Turan D, Esen S, Onder A, Ozaras R, Ozturk R. Permanent visual loss despite appropriate therapy in tuberculous meningitis. South Med J. 2007 Feb;100(2):228-9. doi: 10.1097/SMJ.0b013e31802ef8cd.

Leblebicioglu H, Esen S, Sunbul M, Gunaydin M. Acute hepatitis A virus infection and meningoencephalitis. Ann Saudi Med. 1997 Jan;17(1):86-7. doi: 10.5144/0256-4947.1997.86.

Aksaray S, DokuzoGuz B, Güvener E, Yücesoy M, Yuluğ N, Kocagöz S, Unal S, Cetin S, Calangu S, Günaydin M, Leblebicioğlu H, Esen S, Bayar B, Willke A, Findik D, Tuncer I, Baysal B, Günseren F, Mamikoğlu L. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother. 2000 May;45(5):695-9. doi: 10.1093/jac/45.5.695.

Taşdelen Fişgin N, Darka O, Sünbül M, Coban AY, Sarikaya H, Altun B, Durupinar B, Leblebicioğlu H. [Case report: a nosocomial infection caused by vancomycin resistant enterococcus]. Mikrobiyol Bul. 2005 Jul;39(3):351-5.

Leblebicioglu H, Bayirli D, Esen S, Sunbul M, Eroglu C. Treatment of acute hepatitis C virus infection with interferon-alpha 2b and ribavirin: case report and review of the literature. Ann Clin Microbiol Antimicrob. 2002 Oct 14;1:3. doi: 10.1186/1476-0711-1-3.

Atilla A, Eroğlu C, Esen S, Sünbül M, Leblebicioğlu H. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa]. Mikrobiyol Bul. 2012 Jan;46(1):1-8.

Akcam Z, Sunbul M, Durupinar B, Eroglu C, Esen S, Leblebicioglu H. Tissue types as prognostic risk factor in hepatitis B virus infection. Indian J Gastroenterol. 2002 Jul-Aug;21(4):139-41.

Durupinar B, Yanbeyi S, Leblebicioğlu H, Günaydin M. [Importance of the enzyme-linked immunosorbent assay (ELISA) for the serologic diagnosis of tuberculosis]. Mikrobiyol Bul. 1992 Oct;26(4):338-43.

Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Hirsch MA, ed. UpToDate. Waltham, MA: UpToDate; 2018.

Rojek A, Carson G, Kato Y, Horby PW, Leblebicioglu H. Viral Hemorrhagic Fevers. In: Cohen J, Powderly WG, Opal SM, eds. Infectious Diseases. 4th ed. Elsevier; 2017:1110–1118.e2.

Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine Updates. 19th ed. New York: McGraw Hill Education; 2017.

Pshenichnaya N, Chulanov V, Leblebicioglu H. Epidemiology of Hepatitis B. In: Ozaras R, Tahan V, eds. Viral Hepatitis: Chronic Hepatitis B. Springer, Cham; 2018.

Chulanov V, Pshenichnaya N, Leblebicioglu H. Genetic Diversity of the Hepatitis B Virus and Its Epidemiological Significance. In: Ozaras R, Tahan V, eds. Viral Hepatitis: Chronic Hepatitis B. Springer, Cham; 2018.

Ozaras R, Leblebicioglu H. Global Epidemiology of Hepatitis C Virus Infection. In: Ozaras R, Salmon-Ceron D, eds. Viral Hepatitis: Chronic Hepatitis C. Springer, Cham; 2019.